Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-14

FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application to market a generic fixed-dose combination of lansoprazole, amoxicillin, and clarithromycin for Helicobacter pylori-rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole, Amoxicillin, Clarithromycin (Lansoprazole; Amoxicillin; Clarithromycin)

Snippet

SUPPL AP for LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN (LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN)